Trump imposes 100 percent tariffs on pharmaceuticals:
US President Donald Trump is imposing a 100 percent tariff on all patented medicines ...
bluewin.ch/de/news/wirtschaft-boerse/trump-zolle-medikamente-schweiz-pharma-2889104.html
Photo: bluewin.ch · view article
Trump Implements 100% Tariffs on Branded MedicinesOctober marks the start of 100% tariffs on patented drugs in the US, putting Swiss pharmaceutical exports at risk.
Key FactsSep 26, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: bluewin.ch
Summary created with AI assistance · Source: bluewin.ch
- Starting in early October, the US will impose a 100 percent tariff on all patented pharmaceutical products.
- Exemptions apply to companies that establish or relocate manufacturing operations within the United States.
- Pharmaceuticals represent roughly half of Switzerland’s exports to the US, making them highly vulnerable to tariffs.
- To counteract the impact, Swiss firms such as Roche and Novartis are investing billions in US facilities.
Tariff measures are not an adequate means to sustainably bring production back to the USA.— Fredy Hasenmaile, chief economist at Raiffeisen, discussing Trump's tariff measures.
Story Details
| Last Updated | |
| Total Articles | 5 |
Main Topics
News on this topic
Trump's pharmaceutical tariffs: Impact on Switzerland, Novartis, Roche: Nervousness is high in the global pharmaceutical industry this Friday ...
handelszeitung.ch/unternehmen/neuer-trump-zollhammer-wie-schlimm-trifft-es-die-schweiz-wirklich-865309
Trump imposes tariffs on pharmaceutical products: What you need to know now: Medicines were previously exempt from US punitive tariffs, but Donald Trump ...
tagesanzeiger.ch/trump-verhaengt-pharma-zoelle-das-muessen-sie-wissen-237865464117
Paid articlePaywallSimilar to This
Previous
Novartis ends mid-stage Fabhalta trial targeting serious kidney condition: Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta ...
reuters.com/business/healthcare-pharmaceuticals/novartis-ends-mid-stage-fabhalta-trial-targeting-serious-kidney-condition-2026-10-16/
North Carolina isn't just courting Roche and Novartis: Healthcare companies are investing more than ever before in the US because of the tariffs ...
nzz.ch/wirtschaft/north-carolina-buhlt-nicht-nur-um-roche-und-um-novartis-ld.10010357
Trump: Consequences of the pharmaceutical deal with Novartis and Roche: Two representatives of Swiss corporations appeared with the US President on Friday ...
tagesanzeiger.ch/trump-folgen-des-pharma-deals-mit-novartis-und-roche-766202523672
Paid articlePaywall Swiss pharmaceutical industry: Doom and gloom is misplaced: Novartis is ceasing tablet production in Switzerland. But for more complex products ...
nzz.ch/wirtschaft/schweizer-pharmaindustrie-untergangsstimmung-ist-fehl-am-platz-ld.1914631
US pharmaceutical tariffs: Trump postpones launch - | good for Novartis, Roche: The pharmaceutical tariffs announced for October 1 will not be imposed after all ...
handelszeitung.ch/politik/trump-verschiebt-start-der-neuen-pharmazolle-867041
'Clear risk of recession' if US hits Swiss pharma with 100% tariffs: Switzerland could face recession if Washington slaps its vital pharmaceutical sector with ...
thelocal.ch/20250930/clear-risk-of-recession-if-us-hits-swiss-pharma-with-100-tariff-expert
OpinionTrump's tariffs on pharmaceuticals: Showdown for Novartis and Roche: The industry fears two horror scenarios: Trump's tariffs could hit them harder than ...
tagesanzeiger.ch/trumps-zoelle-fuer-pharma-showdown-fuer-novartis-und-roche-665162060120
Paid articlePaywall Novartis wants to eliminate price difference compared to the USA: The Swiss pharmaceutical company Novartis wants to eliminate the price difference for medicines ...
handelszeitung.ch/newsticker/novartis-will-preisunterschied-zu-den-usa-eliminieren-863236-1
OpinionTrump threatens Switzerland with pharmaceutical tariffs: Industry intends to take advantage of this
tagesanzeiger.ch/trump-droht-schweiz-mit-pharmazoellen-branche-will-das-nutzen-251592273347
Paid articlePaywall OpinionTariffs, price cuts: Trump puts pharmaceutical industry under stress: Swiss drug manufacturers are coming under pressure in their most lucrative sales market ...
nzz.ch/meinung/novartis-roche-und-co-haben-die-schweiz-reich-gemacht-die-pharmabranche-ist-der-falsche-suendenbock-im-zollstreit-ld.1897867
Wake-up call Switzerland: Europe's pharmaceutical giants prepare for the battle against Trump
focus.de/finanzen/boerse/weckruf-schweiz-europas-pharmariesen-ruesten-sich-fuer-die-schlacht-gegen-trump_cdd2a5a9-b458-47ed-841c-c3231042c70a.html
Roche and Novartis relocate pharmaceutical production to the US – Swiss jobs threatened
watson.ch/international/schweiz/197242204-roche-und-novartis-verlagern-pharma-produktion-in-die-usa
Shares in danger, Swiss companies under fire and Keller-Sutter is optimistic: The US government is drastically escalating trade tensions with Switzerland - ...
bluewin.ch/de/news/wirtschaft-boerse/boerse-schwankt-schweizer-wirtschaft-drohen-milliardenverluste-2809604.html
Novartis: CEO threatens to take drugs off the market: Because Trump wants to lower US drug prices, pharmaceutical companies are putting pressure on Europe ...
tagesanzeiger.ch/novartis-ceo-droht-medikamente-vom-markt-zu-nehmen-260987759545
Paid articlePaywall Medicines: Trump's plan could increase Swiss prices: The USA is pushing for lower prices at the expense of Europe. Behind the scenes ...
tagesanzeiger.ch/medikamente-trumps-plan-koennte-schweizer-preise-erhoehen-545348078064
Roche questions US investments due to price cuts: The pharmaceutical companies Roche and Novartis are planning billions of dollars in investments in the USA ...
handelszeitung.ch/unternehmen/roche-stellt-us-investitionen-wegen-preissenkungen-infrage-824017
Roche and Novartis' billion-dollar investments in the US are unpleasant, but the right thing to do.
handelszeitung.ch/unternehmen/keine-zeit-fur-heldentum-819793
Next